Download PDF
Endoscopy 2000; 32(3): 189-199
DOI: 10.1055/s-2000-99
State of the Art Review
Georg Thieme Verlag Stuttgart · New York

Variceal Bleeding and Portal Hypertension

K.F. Binmoeller, R. Borsatto
  • Center for Interventional Endoscopy, University of California San Diego, San Diego, California, USA
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

Within the short span of half a century, the treatment of variceal bleeding has become highly differentiated, with multiple treatment options. Pharmacological therapy with â-blockers is well established for preventing the first variceal bleeding. The utility of adding a vasodilator to â-blockers needs to be studied further. Octreotide is widely used as an adjuvant to standard endoscopic treatment to prevent variceal rebleeding, and the utility of this approach has been validated in several randomized controlled trials. Band ligation is well established, and its popularity has increased with the introduction of multiple ligation devices. The technical simplicity and safety of band ligation has sparked interest in using this technique for primary prophylaxis of variceal bleeding. However, randomized trials have not shown any advantage for band ligation over â-blocker therapy, and the high variceal recurrence rate after band ligation may eliminate any theoretical advantage. A synchronous combination of band ligation and sclerotherapy has not been shown to improve the results of band ligation alone, but a metachronous approach using sclerotherapy to treat recurrent varices after band ligation has shown beneficial results. Histoacryl remains the best treatment option for gastric varices, but band ligation and loop ligation have shown promising results, and should be considered when Histoacryl is not available. Balloon-occluded retrograde transvenous obliteration is a new radiological modality for gastric varices, and one that sounds promising. TIPS is well established as an alternative to elective endoscopic treatment. Compared with endoscopic treatment, TIPS has been shown to improve the survival rate in one randomized trial. However, the cost and complications of TIPS have restricted its use. The use of endoscopic ultrasound for Doppler studies of blood flow in portal hypertension is currently investigational, but it may gain a role in selecting the optimal treatment approach for the individual patient.

References

  • 1 Crafoord C, Frenckner P. New surgical treatment of varicous veins of the oesophagus.  Acta Oto-Laryngologica. 1939;  27 422-429
    PubMedGoogle Scholar
  • 2 Van Stiegmann G, Goff JS. Endoscopic esophageal varix ligation: preliminary clinical experience.  Gastrointest Endosc. 1988;  34 113-117
    PubMedGoogle Scholar
  • 3 Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate.  Endoscopy. 1986;  18 25-26
    PubMedGoogle Scholar
  • 4 Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies.  Ann Surg. 1945;  122 449
    CrossrefPubMedGoogle Scholar
  • 5 Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study.  Radiology. 1969;  92 1112-1114
    PubMedGoogle Scholar
  • 6 Albillos A, Garcia-Pagan JC, Iborra J, et al. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.  Gastroenterology. 1998;  115 116-123
    PubMedGoogle Scholar
  • 7 Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding.  N Engl J Med. 1995;  333 555-560
    CrossrefPubMedGoogle Scholar
  • 8 Jenkins SA, Baxter JN, Critchley M, et al. Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage.  Br Med J. 1997;  315 1338-1341
    PubMedGoogle Scholar
  • 9 Primignani M, Andreoni B, Carpinelli L, et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial (New Italian Endoscopic Club).  Hepatology. 1995;  21 1322-1327
    CrossrefPubMedGoogle Scholar
  • 10 D'Amico G, Politi F, Morabito A, et al. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis: a double-blind, randomized pragmatic trial.  Hepatology. 1998;  28 1206-1214
    CrossrefPubMedGoogle Scholar
  • 11 Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis.  Ann Intern Med. 1995;  123 280-287
    PubMedGoogle Scholar
  • 12 Hou MC, Lin HC, Kuo BI, et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial.  Hepatology. 1995;  21 1517-1522
    CrossrefPubMedGoogle Scholar
  • 13 Sarin SK, Govil A, Jain AK, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
    CrossrefPubMedGoogle Scholar
  • 14 Baroncini D, Milandri GL, Borioni D, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
    PubMedGoogle Scholar
  • 15 De la Peña J, Rivero M, Sanchez E, et al. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial.  Gastrointest Endosc. 1999;  49 417-423
    PubMedGoogle Scholar
  • 16 Sarin SK, Guptan RK, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding.  Eur J Gastroenterol Hepatol. 1996;  8 337-342
    PubMedGoogle Scholar
  • 17 Lay CS, Tsai YT, Teg CY, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.  Hepatology. 1997;  25 1346-1350
    CrossrefPubMedGoogle Scholar
  • 18 Sarin SK, Lamba GS, Kumar M, et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.  N Engl J Med. 1999;  340 988-993
    CrossrefPubMedGoogle Scholar
  • 19 De BK, Ghoshal UC, Das T, et al. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial.  J Gastroenterol Hepatol. 1999;  14 220-224
    CrossrefPubMedGoogle Scholar
  • 20 Svoboda P, Kantorova I, Ochmann J, et al. A prospective randomized controlled trial of sclerotherapy vs. ligation in the prophylactic treatment of high-risk esophageal varices.  Surg Endosc. 1999;  13 580-584
    CrossrefPubMedGoogle Scholar
  • 21 Gotoh Y, Iwakiri R, Sakata Y, et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy.  J Gastroenterol Hepatol. 1999;  14 241-244
    CrossrefPubMedGoogle Scholar
  • 22 Laine L, Stein C, Sharma V. Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices.  Gastroenterology. 1996;  110 529-533
    PubMedGoogle Scholar
  • 23 Saeed ZA, Stiegmann GV, Ramirez FC, et al. Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: a multicenter prospective randomized trial.  Hepatology. 1997;  25 71-74
    CrossrefPubMedGoogle Scholar
  • 24 Al Traif I, Fachartz FS, Al Jumah A, et al. Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices.  Gastrointest Endosc. 1999;  50 1-6
    CrossrefPubMedGoogle Scholar
  • 25 Djurdjevic D, Janosevic S, Dapcevic B, et al. Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.  Endoscopy. 1999;  31 286-290
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Umehara M, Onda M, Tajiri T, et al. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study.  Gastrointest Endosc. 1999;  50 7-12
    PubMedGoogle Scholar
  • 27 Garg PK, Joshi YK, Tandon RK. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study.  Gastrointest Endosc. 1999;  50 369-373
    CrossrefPubMedGoogle Scholar
  • 28 Lo GH, Lai KH, Cheng JS, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial.  Hepatology. 1998;  28 391-395
    CrossrefPubMedGoogle Scholar
  • 29 Chen SM, Lo GH, Lai KH, et al. Influence of endoscopic variceal ligation on oesophageal motility.  J Gastroenterol Hepatol. 1999;  14 231-235
    CrossrefPubMedGoogle Scholar
  • 30 D'Imperio N, Piemontese A, Baroncini D, et al. Evaluation of undiluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices.  Endoscopy. 1996;  28 239-243
    PubMedGoogle Scholar
  • 31 Oho K, Iwao T, Sumino M, et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.  Endoscopy. 1995;  27 349-354
    PubMedGoogle Scholar
  • 32 Ramond MJ, Valla D, Mosnier JF, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate.  Hepatology. 1989;  10 488-493
    PubMedGoogle Scholar
  • 33 Binmoeller KF, Soehendra N. “Superglue”: the answer to variceal bleeding and fundal varices? [editorial].  Endoscopy. 1995;  27 392-396
    PubMedGoogle Scholar
  • 34 Ogawa K, Ishikawa S, Naritaka Y, et al. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.  J Gastroenterol Hepatol. 1999;  14 245-250
    CrossrefPubMedGoogle Scholar
  • 35 Miyazaki S, Yoshida T, Harada T, et al. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.  Hepatogastroenterology. 1998;  45 1155-1158
    PubMedGoogle Scholar
  • 36 Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique.  Gastrointest Endosc. 1999;  49 437-441
    CrossrefPubMedGoogle Scholar
  • 37 Cipolletta L, Bianco MA, Rotondano G, et al. Emergency endoscopic ligation of actively bleeding gastric varices with a detachable snare.  Gastrointest Endosc. 1998;  47 400-403
    PubMedGoogle Scholar
  • 38 Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.  J Gastroenterol Hepatol. 1996;  11 51-58
    PubMedGoogle Scholar
  • 39 Hirota S, Matsumoto S, Tomita M, et al. Retrograde transvenous obliteration of gastric varices.  Radiology. 1999;  211 349-356
    PubMedGoogle Scholar
  • 40 Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices.  Am J Gastroenterol. 1999;  94 643-649
    CrossrefPubMedGoogle Scholar
  • 41 Hamamoto N, Matsumoto A, Nomura T, et al. Treatment of gastric fundal varices by balloon endoscopic sclerotherapy.  Gastrointest Endosc. 1999;  49 115-118
    PubMedGoogle Scholar
  • 42 Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial.  Ann Intern Med. 1997;  126 858-865
    PubMedGoogle Scholar
  • 43 Garcia-Villarreal L, Martinez-Lagares F, Sierra A, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.  Hepatology. 1999;  29 27-32
    CrossrefPubMedGoogle Scholar
  • 44 Chau TN, Patch D, Chan YW, et al. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding.  Gastroenterology. 1998;  114 981-987
    PubMedGoogle Scholar
  • 45 Meddi P, Merli M, Lionetti R, et al. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.  Hepatology. 1999;  29 1074-1077
    CrossrefPubMedGoogle Scholar
  • 46 Urata J, Yamashita Y, Tsuchigame T, et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy.  J Gastroenterol Hepatol. 1998;  13 1061-1067
    PubMedGoogle Scholar
  • 47 Nahass GT, Cornelius L. Fluoroscopy-induced radiodermatitis after transjugular intrahepatic portosystemic shunt.  Am J Gastroenterol. 1998;  93 1546-1549
    CrossrefPubMedGoogle Scholar
  • 48 Willner IR, El-Sakr R, Werkman RF, et al. A fistula from the portal vein to the bile duct: an unusual complication of transjugular intrahepatic portosystemic shunt.  Am J Gastroenterol. 1998;  93 1952-1955
    CrossrefPubMedGoogle Scholar
  • 49 Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts.  Gastroenterology. 1998;  115 110-115
    PubMedGoogle Scholar
  • 50 Leung VK, Sung JJ, Ahuja AT, et al. Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding.  Gastroenterology. 1997;  112 1811-1816
    PubMedGoogle Scholar
  • 51 Lo GH, Lai KH, Cheng JS, et al. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy.  Gastrointest Endosc. 1999;  49 428-436
    PubMedGoogle Scholar
  • 52 Schiano TD, Adrain AL, Vega KJ, et al. High-resolution endoluminal sonography assessment of the hematocystic spots of esophageal varices.  Gastrointest Endosc. 1999;  49 424-427
    CrossrefPubMedGoogle Scholar
  • 53 Lee YT, Sung JJ, Yung MY, et al. Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension.  Gastrointest Endosc. 1999;  50 47-52
    PubMedGoogle Scholar
  • 54 Sato T, Yamazaki K, Toyota J, et al. Perforating veins in recurrent esophageal varices after endoscopic therapy visualized by endoscopic color Doppler ultrasonography.  Dig Endosc. 1999;  11 236-240
    PubMedGoogle Scholar

M.D. M.D. K. F. Binmoeller
K. F. Binmoeller
K. F. Binmoeller

UCSD Medical Center

200 W. Arbor Drive

San Diego, CA 92103-8413

USA

Associate Professor of Medicine and Surgery, Director of Endoscopy

Phone: +1-619-543-2766

Email: kbinmoeller@ucsd.edu